Silvio Danese

218PUBLICATIONS
370CO-AUTHORS
Predictive and prognostic markersMajor global burdens of diseaseToxicology (incl. clinical toxicology)Infant and child healthCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (218)

|Aug 08, 2026
Comparative risk of postoperative complications in ulcerative colitis patients following preoperative advanced therapies: a network meta-analysis with meta-regression.

|Jul 28, 2026
Risk of serious infection, myocardial infarction, stroke, and thromboembolic events in patients in the United States with ulcerative colitis treated with tofacitinib compared with biologic treatments.

|Jul 21, 2026
Corticosteroid-sparing effects of risankizumab versus ustekinumab in patients with moderately to severely active Crohn's disease: post hoc results from the phase 3b SEQUENCE trial.

|Jul 16, 2026
Comparative performance of intestinal ultrasound activity indices in pediatric ulcerative colitis: a prospective study.

|Jul 15, 2026
Machine Learning for Colitis-Associated Cancer in Inflammatory Bowel Disease: Evidence and Future Directions Toward Precision Medicine, a Narrative Review.

|May 20, 2026
Time to rethink washout periods in inflammatory bowel disease clinical trials: an international Delphi consensus.

Pageof 37

Frequent Collaborators

52 joint publications

Laurent Peyrin-Biroulet

16 joint publications

Ferdinando D'Amico

16 joint publications

Fernando Magro

16 joint publications

Séverine Vermeire